These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3673907)

  • 1. Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator.
    Guarnieri T; Levine JH; Veltri EP; Griffith LS; Watkins L; Juanteguy J; Mower MM; Mirowski M
    Am J Cardiol; 1987 Nov; 60(13):1061-4. PubMed ID: 3673907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular pacing threshold and time to capture postdefibrillation in patients undergoing implantable cardioverter-defibrillator implantation.
    Khastgir T; Lattuca J; Aarons D; Murphy J; O'Mara V; Juanteguy J; Veltri EP
    Pacing Clin Electrophysiol; 1991 May; 14(5 Pt 1):768-72. PubMed ID: 1712951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator.
    Huang SK; Tan de Guzman WL; Chenarides JG; Okike NO; Vander Salm TJ
    Am Heart J; 1991 Sep; 122(3 Pt 1):720-7. PubMed ID: 1877448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic amiodarone therapy on defibrillation threshold.
    Jung W; Manz M; Pizzulli L; Pfeiffer D; Lüderitz B
    Am J Cardiol; 1992 Oct; 70(11):1023-7. PubMed ID: 1414899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antiarrhythmic drugs on epicardial defibrillation energy requirements and the rate of defibrillator discharges.
    Jung W; Manz M; Pfeiffer D; Tebbenjohanns J; Pizzulli L; Lüderitz B
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 2):198-201. PubMed ID: 7681571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful implantation of cardioverter-defibrillator systems in patients with elevated defibrillation thresholds.
    Brooks R; Torchiana D; Vlahakes GJ; Ruskin JN; McGovern BA; Garan H
    J Am Coll Cardiol; 1993 Aug; 22(2):569-74. PubMed ID: 8335831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-energy endocardial defibrillation using dual, triple, and quadruple electrode systems.
    Munsif AN; Saksena S; DeGroot P; Krol RB; Matthew P; Giorgberidze I; Kaushik RR; Mehra R
    Am J Cardiol; 1997 Jun; 79(12):1632-9. PubMed ID: 9202354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator. Nonthoracotomy approach to implantation.
    Yee R; Klein GJ; Leitch JW; Guiraudon GM; Guiraudon CM; Jones DL; Norris C
    Circulation; 1992 Jan; 85(1):196-204. PubMed ID: 1728450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
    Hohnloser SH; Dorian P; Roberts R; Gent M; Israel CW; Fain E; Champagne J; Connolly SJ
    Circulation; 2006 Jul; 114(2):104-9. PubMed ID: 16818810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late results of the left subcostal approach for automatic implantable cardioverter defibrillator implantation.
    O'Neill PG; Lawrie GM; Kaushik RR; Harvill LF; Pacifico A
    Am J Cardiol; 1991 Feb; 67(5):387-90. PubMed ID: 1994663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures.
    Marchlinski FE; Flores BT; Buxton AE; Hargrove WC; Addonizio VP; Stephenson LW; Harken AH; Doherty JU; Grogan EW; Josephson ME
    Ann Intern Med; 1986 Apr; 104(4):481-8. PubMed ID: 3954276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The automatic implantable cardioverter-defibrillator: effect of patch polarity on defibrillation threshold.
    O'Neill PG; Boahene KA; Lawrie GM; Harvill LF; Pacifico A
    J Am Coll Cardiol; 1991 Mar; 17(3):707-11. PubMed ID: 1993791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The implantable automatic cardioverter-defibrillator].
    Klein H; Tröster J; Trappe HJ; Becht I; Siclari F
    Herz; 1990 Apr; 15(2):111-25. PubMed ID: 2188891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of high initial epicardial patch defibrillation thresholds following chronic implantation.
    Grubb BP; Mancini M; Temesy-Armos P; Hahn H; Elliott L
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 1):149-51. PubMed ID: 1706497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between drugs and devices: experimental and clinical studies.
    Manz M; Jung W; Lüderitz B
    Am Heart J; 1994 Apr; 127(4 Pt 2):978-84. PubMed ID: 8160602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of complications associated with a first-generation endocardial defibrillation lead system for implantable cardioverter-defibrillators.
    Tullo NG; Saksena S; Krol RB; Mauro AM; Kunecz D
    Am J Cardiol; 1990 Aug; 66(4):411-5. PubMed ID: 2386116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic drug therapy as an adjunct or alternative to an implantable cardioverter defibrillator.
    Prystowsky EN
    Pacing Clin Electrophysiol; 1992 Apr; 15(4 Pt 3):678-80. PubMed ID: 1375370
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective, randomized evaluation of effect of ventricular fibrillation duration on defibrillation thresholds in humans.
    Bardy GH; Ivey TD; Allen M; Johnson G
    J Am Coll Cardiol; 1989 May; 13(6):1362-6. PubMed ID: 2703617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful defibrillation by disconnection of superior vena cava electrode for high defibrillation threshold: a case report].
    Matsushita K; Ishikawa T; Sumita S; Kobayashi T; Kawasaki N; Matsumoto K; Taima M; Uchino K; Kimura K; Umemura S
    J Cardiol; 2005 Jan; 45(1):27-32. PubMed ID: 15700927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.